Myriad Genetics, Inc., (NASDAQ: MYGN), a leader in genetic testing and precision medicine, continues to empower parents with increased access to prenatal testing. SneakPeek, the #1 OBGYN-recommended ...

Millions of people have used its simple genetic testing service ... about other companies that also collect our DNA?

Concerns about 23andMe's business prospects is raising questions about the genetic testing company's customer data.

No. 23andMe is considered a direct-to-consumer genetic testing company, and transactions with the company are considered commercial, not medical. Because 23andMe is not a medical company, customers' ...

A company representative shows off what is in a DNA kit at the 23andMe booth at the RootsTech ... and discontinuing its ...

Researchers at University of California San Francisco (UCSF) have developed a single genomic test that can quickly detect ...

The global genomics market is expected to reach USD 66.85 billion in 2029 from USD 42.64 billion in 2024, at a CAGR of 9.4% ...

In yet another blow to the DNA-testing industry, Atlas Biomed, a London-based genetic firm with links to Russia, has disappeared without any warning.

The latest Market Talks covering the Health Care sector. Published exclusively on Dow Jones Newswires at 4:20 ET, 12:20 ET and 16:50 ET.0616 GMT – Mega Lifesciences is facing pressure from a ...

Jessica Ko saw others sharing their DNA results online and decided to take a test. The results have changed how she sees ...